TY - JOUR
T1 - SPOP is essential for DNA-protein cross-link repair in prostate cancer cells
T2 - SPOP-dependent removal of topoisomerase 2A from the topoisomerase 2A-DNA cleavage complex
AU - Watanabe, Ryuta
AU - Maekawa, Masashi
AU - Hieda, Miki
AU - Taguchi, Tomohiko
AU - Miura, Noriyoshi
AU - Kikugawa, Tadahiko
AU - Saika, Takashi
AU - Higashiyama, Shigeki
N1 - Funding Information:
We thank Mami Chosei, Ayako Fujisaki, Tomohisa Sakaue, Yuuki Imai, and Tatsuya Sawasaki (Ehime University) for providing their technical assistance, Shinji Fukuda (Ehime University) for comments on this work, and Jun Nakayama and Kentaro Semba (Waseda University) for providing useful information on this work. This work was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant no. 19K18613 (R.W.), JSPS KAKENHI Grant no. 18K15244, The Mochida Memorial Foundation for Medical and Pharmaceutical Research, The Uehara Memorial Foundation (M.M.), JSPS KAKENHI Grant no. 17K11142 (T.K.), the Takeda Science Foundation, Proteo-Science Center, and AMED P-CREATE Grant no. 19cm0106238h0002 to S.H.
Publisher Copyright:
© 2020 Watanabe, Maekawa, et al.
PY - 2020/3/15
Y1 - 2020/3/15
N2 - SPOP, speckle-type POZ protein is a substrate adaptor protein of the Cullin-3/ RING ubiquitin E3 complex. The spop gene is the most commonly point mutated in human primary prostate cancers, but the pathological contribution of the SPOP mutations remains unclear. In this study, we investigated several known factors that are critical in the DNA-protein cross-link repair process. The depletion of SPOP or overexpression of a prostate cancer-associated SPOP mutant, F133V, in androgen receptor-positive prostate cancer cells increased the amount of topoisomerase 2A (TOP2A) in the nuclei together with the increased amount of γH2AX, an indication of DNA breaks. Tyrosyl-DNA phosphodiesterases (TDPs) and an endo/exonuclease MRE11 are enzymes that liberate TOP2A from the TOP2A-DNA cleavage complex, and thus is essential for the completion of the DNA repair process. We found that the amount of TDP1 and TDP2 was decreased in SPOP-depleted cells, and that of TDP2 and MRE11 was decreased in F133V-overexpressing cells. These results suggest that the F133V mutant exerts dominant-negative and gain-of-function effects in down-regulation of TDP2 and MRE11, respectively. We conclude that SPOP is involved in the DNA-protein cross-link repair process through the elimination of TOP2A from the TOP2A cleavage complex, which may contribute to the genome stability.
AB - SPOP, speckle-type POZ protein is a substrate adaptor protein of the Cullin-3/ RING ubiquitin E3 complex. The spop gene is the most commonly point mutated in human primary prostate cancers, but the pathological contribution of the SPOP mutations remains unclear. In this study, we investigated several known factors that are critical in the DNA-protein cross-link repair process. The depletion of SPOP or overexpression of a prostate cancer-associated SPOP mutant, F133V, in androgen receptor-positive prostate cancer cells increased the amount of topoisomerase 2A (TOP2A) in the nuclei together with the increased amount of γH2AX, an indication of DNA breaks. Tyrosyl-DNA phosphodiesterases (TDPs) and an endo/exonuclease MRE11 are enzymes that liberate TOP2A from the TOP2A-DNA cleavage complex, and thus is essential for the completion of the DNA repair process. We found that the amount of TDP1 and TDP2 was decreased in SPOP-depleted cells, and that of TDP2 and MRE11 was decreased in F133V-overexpressing cells. These results suggest that the F133V mutant exerts dominant-negative and gain-of-function effects in down-regulation of TDP2 and MRE11, respectively. We conclude that SPOP is involved in the DNA-protein cross-link repair process through the elimination of TOP2A from the TOP2A cleavage complex, which may contribute to the genome stability.
UR - http://www.scopus.com/inward/record.url?scp=85081914492&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081914492&partnerID=8YFLogxK
U2 - 10.1091/mbc.E19-08-0456
DO - 10.1091/mbc.E19-08-0456
M3 - Article
C2 - 31967940
AN - SCOPUS:85081914492
SN - 1059-1524
VL - 31
SP - 478
EP - 490
JO - Molecular Biology of the Cell
JF - Molecular Biology of the Cell
IS - 6
ER -